ClinVar Miner

Submissions for variant NM_000540.3(RYR1):c.10616G>A (p.Arg3539His) (rs143987857)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000119414 SCV000232393 uncertain significance not provided 2016-08-01 criteria provided, single submitter clinical testing
GeneDx RCV000119414 SCV000234974 uncertain significance not provided 2018-03-22 criteria provided, single submitter clinical testing The R3539H variant in the RYR1 gene has been reported previously in the heterozygous state, and opposite of another RYR1 variant, in individuals with core myopathies, and in other individuals with malignant hyperthermia (Monnier et al., 2008; Snoeck et al., 2015; Brandom et al., 2013; Klein et al., 2012; Voermans et al., 2013). The R3539H variant was also observed in unaffected individuals in control populations and in cohort studies (Brandom et al., 2013; Dorschner et al., 2013). The R3539H variant is observed in 384/126088 (0.30%) alleles from individuals of non-Finnish European background, including one homozygous individual in large population cohorts (Lek et al., 2016). The R3539H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. We interpret R3539H as a variant of uncertain significance.
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics,Children's Hospital of Philadelphia RCV000203202 SCV000257708 uncertain significance not specified 2015-06-18 criteria provided, single submitter clinical testing
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000209955 SCV000265737 uncertain significance Malignant hyperthermia, susceptibility to, 1 2013-07-01 criteria provided, single submitter research
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000203202 SCV000540251 uncertain significance not specified 2017-01-24 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This variant is classified in HGMD as DM relating to central core disease and is reported in 10 papers, with comments suggesting VUS/LB. This variant has a Max MAF of 0.30% in ExAC (384/126200 European chrs including 1 homozygote - high for central core disease prevalence of 6/100,000). It is classified in ClinVar as VUS by 4 submitters (Emory, GeneDx, CHOP, Biesecker), and Likely benign by U Wash.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000119414 SCV000575180 uncertain significance not provided 2020-08-01 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000203202 SCV000596887 uncertain significance not specified 2017-02-02 criteria provided, single submitter clinical testing
Invitae RCV001085699 SCV000659754 likely benign RYR1-Related Disorders 2020-12-01 criteria provided, single submitter clinical testing
PreventionGenetics,PreventionGenetics RCV000119414 SCV000852216 uncertain significance not provided 2016-05-25 criteria provided, single submitter clinical testing
Mendelics RCV000209955 SCV001141071 benign Malignant hyperthermia, susceptibility to, 1 2019-05-28 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000119414 SCV001474664 uncertain significance not provided 2020-03-24 criteria provided, single submitter clinical testing
Leiden Muscular Dystrophy (RYR1) RCV000119414 SCV000154321 not provided not provided no assertion provided not provided
CSER _CC_NCGL, University of Washington RCV000148796 SCV000190534 likely benign Central core myopathy 2014-06-01 no assertion criteria provided research
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000119414 SCV001552609 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.